Company / PP&E (Net)
Edesa Biotech, Inc. PP&E (Net) History
FY2014-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$15.0K
FY2021
5-year range
$14.8K / $1.1M
FY2017-FY2021
Trend
+1.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $14,989 over the past 3 years.
Based on SEC 10-K filings.
$14,989 in FY2021 with a 5-year CAGR of -54.4%.
Declined from $1M to $14,989 over the past 3 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -75.8%
- 5-Year CAGR
- -54.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -54.4%, indicating a declining trend.
- In FY2021, pp&e (net) increased 1.2% year-over-year.
- Peak pp&e (net) was recorded in FY2018.
- Lowest pp&e (net) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2021 | $15.0K | +1.2% |
| FY2020 | $14.8K | -98.6% |
| FY2018 | $1.1M | +20.8% |
| FY2017 | $879.5K | +16.3% |
| FY2016 | $756.1K | +95.2% |
| FY2015 | $387.4K | +0.0% |
| FY2014 | $387.4K | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026